Essum

Essum is a Swedish biotechnology company specializing in the research and development of probiotic lactic acid bacteria for human health applications. The company focuses on the therapeutic potential of the microbiome, particularly in dermatology and gastroenterology, utilizing its proprietary strains like Lactobacillus coryniformis LB244. Essum's lead programs target atopic dermatitis and skin barrier function, aiming to provide natural, evidence-based alternatives to traditional pharmacological treatments. Their business model encompasses both internal product development and licensing of their specialized bacterial strains to global partners in the healthcare and skincare industries. The company is a spin-off from Umeå University and maintains a strong foundation in clinical research.